You Brexit, You Buy It – Europe and the New Regulatory – Part 1 of 2 By Lynn Hansen, Director of Clinical and Regulatory Affairs, Pharmatech Associates With Brexit looming, questions and concerns hover like a grey cloud over the UK pharmaceutical industry. Industry insiders and colleagues in London found that the confusion surrounding what…
Hurry Up and Wait: Brexit from a Regulatory Point of View – Part 2
You Brexit, You Buy It – Europe and the New Regulatory – Part 2 By Lynn Hansen, Director of Clinical and Regulatory Affairs, Pharmatech Associates In Brexit Part 1, I expressed my Brexit thoughts as Theresa May was providing a tearful resignation and now the United Kingdom has the return of an energetic Boris Johnson,…
Pfizer to Buy Array Biopharma in Deal Worth $11.4B
Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array, whose product portfolio includes a treatment combination used…
Psoriasis Treatment Market to Gain $121 Billion by 2024
As reported by TMR, the global psoriasis treatment market is prognosticated to exhibit a 5.10 percent CAGR over the forecast period from 2016 to 2024. The market was estimated to be worth $7.8 bn in 2015 and is forecasted to reach $12.1 bn by 2024. North America is predicted to emerge as the leading region…
ADHD Drugs Market Will Register a CAGR of Almost 6 Percent by 2023
The rising incidence rate of ADHD among children is one of the critical factors that will trigger the growth of the attention deficit hyperactivity disorder drugs market. The expansion of the patient pool with positive ADHD symptoms is fueling the demand for ADHD therapies. As per the CDC, in 2016. Approximately 9.4 percent of children…
FDA Approves First Chemotherapy Regimen for Relapsed Diffuse Large B-cell Lymphoma
Computational Biology Market Size Worth $13.6 Billion by 2026
Antifreeze Proteins Market Will Register a CAGR of Over 30 Percent by 2023
Impending Patent Cliff Threatens Billions of Global Prescription Drug Sales
Over $198 billion in global prescription drug sales are at risk between 2019-2024 from patent expirations, according to a new report from EvaluatePharma. Experts are now warning that the pharmaceutical industry is on the brink of a second patent cliff. Worldwide prescription drug sales are expected to grow at a CAGR of 6.9 percent to $842…
FDA Approves First Treatment for Episodic Cluster Headache
The U.S. Food and Drug Administration approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults. “Emgality provides patients with the first FDA-approved drug that reduces the frequency of attacks of episodic cluster headache, an extremely painful and often debilitating condition,” said Eric Bastings, M.D., deputy director of the Division…